Jason E. Imbriglio

Statistics

Publications

Citations

1.8K

H-Index

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Boston College

University of Arizona

Arena Pharmaceuticals (United States)

Harvard University

Jason E. Imbriglio is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, biochemistry, and chemistry.

Publications per year

1997–2022

Publications

Triglyceride Synthesis by DGAT1 Protects Adipocytes from Lipid-Induced ER Stress during Lipolysis

Chandramohan Chitraju, Niklas Mejhert, Joel T. Haas et al. · Cell Metabolism · 2017 · 361 citations · Full text

Life Sciences, Biochemistry, Cell Biology +14

Dual Catalyst Control in the Amino Acid-Peptide-Catalyzed Enantioselective Baylis−Hillman Reaction

Jason E. Imbriglio, Melissa M. Vasbinder, Scott J. Miller · Organic Letters · 2003 · 165 citations

Natural Sciences, Chemistry, Catalysis +3

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®

Timothy A. Blizzard, Helen Chen, Seongkon Kim et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 161 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Model Systems for Flavoenzyme Activity: One- and Two-Electron Reduction of Flavins in Aprotic Hydrophobic Environments

Angelika Niemz, Jason E. Imbriglio, Vincent M. Rotello · Journal of the American Chemical Society · 1997 · 143 citations

Natural Sciences, Biochemistry, Chemistry +15

Nucleophilic <i>Ortho</i> Allylation of Aryl and Heteroaryl Sulfoxides

Andrew J. Eberhart, Jason E. Imbriglio, David J. Procter · Organic Letters · 2011 · 137 citations

Natural Sciences, Chemistry, Organic Chemistry +9

1–5 of 23